An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy

Eur J Med Chem. 2017 Jul 28:135:241-259. doi: 10.1016/j.ejmech.2017.04.044. Epub 2017 Apr 21.

Abstract

The azole antifungal drugs are an important class of chemotherapeutic agents with broad-spectrum of activity against yeasts and filamentous fungi, act in the ergosterol biosynthetic pathway through inhibition of the cytochrome P450-dependent enzyme sterol 14α-demethylase. Azole antifungals have also been repurposed for treatment of tropical protozoan infections including human leishmaniasis. Recent advances in molecular biology and computational chemistry areas have increased our knowledge about sterol biochemical pathway in Leishmania parasites. Based on the importance of sterol biosynthetic pathway in Leishmania parasites, we reviewed all studies reported on azoles for potential antileishmanial therapy along their structural and biological aspects. This review may help medicinal chemists for design of new azole-derived antileishmanial drugs.

Keywords: Antileishmanial agents; Azole antifungals; Imidazole; Leishmaniasis; Sterol 14α-demethylase; Triazole.

Publication types

  • Review

MeSH terms

  • 14-alpha Demethylase Inhibitors / chemical synthesis
  • 14-alpha Demethylase Inhibitors / chemistry
  • 14-alpha Demethylase Inhibitors / pharmacology*
  • Antiprotozoal Agents / chemical synthesis
  • Antiprotozoal Agents / chemistry
  • Antiprotozoal Agents / pharmacology*
  • Azoles / chemical synthesis
  • Azoles / chemistry
  • Azoles / pharmacology*
  • Humans
  • Leishmania / drug effects*
  • Molecular Structure
  • Sterol 14-Demethylase / metabolism*

Substances

  • 14-alpha Demethylase Inhibitors
  • Antiprotozoal Agents
  • Azoles
  • Sterol 14-Demethylase